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Vitamin D yesterday, today, tomorrow
Nora Nikolac Gabaj
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
In the last decade, vitamin D has become one of 
the most frequently ordered tests worldwide. In 
France, frequency of vitamin D testing has in-
creased 10-fold in the last ten years, amounting to 
150 million EUR spent for testing in private labs. In 
USA vitamin D has become 5th most commonly 
ordered test in Medicare healthcare system. Ex-
pansion of vitamin D testing is a result of many 
promising observational studies that have associ-
ated vitamin D concentration with health benefits 
in cardiovascular diseases, cancer, diabetes, fertili-
ty and many others. Number of published papers 
increases daily, however, all are not confirming ini-
tial findings. 
Based on the Croatian guideline for prevention, 
detection and therapy of vitamin D deficiency in 
adults, issued in 2016 by several professional soci-
eties, concentrations lower than 30 nmol/L are 
considered as extreme deficiency, < 50 nmol/L as 
deficiency and < 75 nmol/L as insufficiency. Data 
collected from the Department of Clinical Chemis-
try, Sestre milosrdnice University Hospital Center 
showed that out of 11,863 patients tested for vita-
min D in 2018, only 2901 (26%) had vitamin D con-
centration > 75 nmol/L. Recommended daily in-
take of vitamin D for adults is 600 IU, and if suffi-
cient amount is not ingested by food, supple-
ments should be taken.
Usage of dietary supplements has become more 
increasing in recent years. In USA, in 2018 market 
share for vitamins has accounted for 37.64 billion 
USD. Large European multicentre study published 
in 2018 on patient’s knowledge and awareness 
about the effect of the over-the-counter drugs 
and dietary supplements on laboratory test re-
sults, has revealed some alarming issues. More 
than two thirds of patients are taking at least one 
dietary supplement, but they are usually not re-
porting the usage neither to their physicians nor 
to the laboratory staff. Our recent study has shown 
that methods for vitamin D measurement might 
react differently when vitamin D is measured in 
patients who are taking vitamin D supplements 
and those who are not. Usage of any supplements 
that might affect laboratory testing should be re-
ported to laboratory staff.
Corresponding author: nora.nikolac@gmail.com
Mechanism of action and physiologic 
function of vitamin D
Adriana Unić
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
Vitamin D and its metabolites are steroid hor-
mones and hormone precursors. About 80% of vi-
tamin D3 is produces by UVB irradiation of the 
7-dehydrocholesterol in the skin, and the remain-
der comes from the diet and food supplements 
mainly in the form of vitamin D2 (with the excep-
tion of fatty fish). Vitamin D2 is produced by UVB 
irradiation in plants and fungi. Regardless of ori-
gin, vitamins D2 and D3 are biologically inactive 
before two hydroxylation processes in the liver 
and the kidney preceding the formation of the bi-
ologically active form of vitamin D, 1,25(OH)2D. 
All genomic actions of 1, 25(OH)2D are mediated 
by vitamin D binding protein (VDBP). Vitamin D 
and its metabolites are transported in the circula-
tion by VDBP, and when reaching their target cells, 
they dissociate from the VDBP, enter the cells and 
interact with a nuclear vitamin D receptor (VDRn). 
VDRn was detected in various tissues and cells and 
functions as a transcription factor. Liganded VDRn 
forms a heterodimeric complex with Retinoid-X-
Receptor (RXR) and up regulates or down regu-
lates the expression of target genes through bind-
ing to the responsible elements in the promoter 
region of the regulated gene (VDREs) initiating a 
formation of an assembly of nuclear transcription 
factors. 
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However, some effects of vitamin D in target cells 
are too rapid to be explained by stimulation of 
gene expression. It is recognized that 1,25(OH)2D 
also act trough non-genomic actions that are 
mainly manifest as the activation of intracellular 
signalling molecules and consequently transcrip-
tion factors that bind to the VDRE. Another non-
genomic action of 1,25(OH)2D includes the regula-
tion of VDR binding to target receptors such as 
STAT1 and IKKβ. Non-genomic effects of 
1,25(OH)2D are mediated by membrane VDR 
(VDRm). 
Biological effects of vitamin D are well known. The 
major targets of 1,25(OH)2D are intestine, kidney 
and bones, where, together with other calciotrop-
ic hormones, maintains calcium balance. In addi-
tion to classic actions related to mineral homeo-
stasis, vitamin D has novel actions in cell prolifera-
tion and differentiation, regulation of the innate 
and adaptive immune system, preventive effects 
on neurodegenerative and cardiovascular diseas-
es, and antiaging effects. 
Corresponding author: adrianaunic@gmail.com
Effect of preanalytical factors on 
vitamin D concentration
Marijana Miler
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
In the last few years requests for vitamin D deter-
mination is increasing. The main reason for such 
rise is that vitamin D deficiency proved to be asso-
ciated with various diseases, especially bone met-
abolic diseases, but also cardiovascular, autoim-
mune, neurodegenerative diseases, diabetes and 
some cancers. In order to be sure that deficiency is 
discovered, vitamin D concentration should be de-
termined accurately and precisely. For accurate 
definition of vitamin D deficiency, it is necessary to 
know all, or as much as possible, preanalytical is-
sues that could affect results or interpretation of 
results. 
Published studies proved that vitamin D metabo-
lite 25-hydroxy vitamin D 25(OH)D is very stable 
analyte in almost all storage conditions. Concen-
tration of 25(OH)D is stable for days at room tem-
perature, for years at - 20⁰C, and even multiple 
freeze-thaw cycles do not change results. Both se-
rum and plasma can be used for measurement of 
25(OH)D concentration, without statistically signif-
icant difference in results. 
As declared by the commonly used manufactur-
ers, only high levels of endogenous interferences 
can affect results, for example, haemolysis above 2 
g/L of free haemoglobin, icteria above 342 µmol/L 
or high lipemia (with triglycerides above 3 
mmol/L). 
However, due to characteristic pathway and me-
tabolism of vitamin D, some specific preanalytical 
issues are known. Concentration of vitamin D 
could be affected with amount of UV light, de-
pending on seasonal or geographical variations, 
amount of exposure to sun, or sunscreen protec-
tion. Moreover, skin type and colour could also 
produce different concentration of active form of 
vitamin D in the blood. Women usually have lower 
concentration of vitamin D than men. Further-
more, different dietary habits, as well as body 
mass index influence on vitamin D concentration. 
A great number of patients take some food sup-
plements with vitamin D, which could also affect 
measurement accuracy. 
It is very important to be aware of all of these, and 
some others, preanalytical factors that could af-
fect interpretation of results and lead to possible 
misdiagnosis of vitamin D deficiency. 
Corresponding author: marijana.miler@gmail.com 
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Analytical challenges in determining 
vitamin D
Tomislav Pavičić
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
General acceptance of serum total 25-hydroxyvi-
tamin D (25(OH)D) as the best biomarker of an in-
dividual’s vitamin D status has resulted in the de-
velopment of several specific and sensitive com-
mercial assays over the past 20 years. Its hydro-
phobic nature, small circulating concentrations, 
ability to bind to lipids and vitamin D binding pro-
teins (VDBP), and presence of multiple vitamin D 
metabolites in bloodstream have defined 25(OH)D 
as a “difficult analyte”. Precise and accurate meas-
urement of 25(OH)D concentrations is challenging, 
and large variations exist between different assay 
methodologies. Such variations depend on sever-
al factors: different methods of vitamin D extrac-
tion and deproteinization, antibody cross-reactivi-
ty with epimers and/or other vitamin D metabo-
lites, and presence of isobaric compounds or ma-
trix interferences. Assays based on liquid chroma-
tographic techniques (LC) or mass spectrometry 
(MS) are more accurate than the automated 
chemiluminescent immunoassay-based methods. 
Since the above mentioned methods are usually 
based on achiral chromatographic techniques, 
they cannot distinguish between 25(OH)D3 and its 
3-epimer, or other isobaric compounds (e.g. 
7-α-hydroxy-4-cholesten-3-one, an endogenous 
precursor of bile acids) resulting in a slight overes-
timation of concentrations. Currently isotope-dilu-
tion LC/MS-MS is considered the gold standard 
method. The large discrepancies between LC-MS 
methods and immunoassays, but also among dif-
ferent immunoassay methods, are mainly due to 
differences in cross-reactivity with various vitamin 
D metabolites, which accounts for a significant 
proportion of total 25(OH)D. Although immunoas-
says do not detect 3-epi-25(OH)D3, generating 
specific antibodies against small antigenic mole-
cules such as 25(OH)D is difficult, and cross-reac-
tivity with 24,25(OH)2D3 and other vitamin D me-
tabolites is common. While some immunoassays 
cannot detect 25(OH)D2, those that can are unable 
to distinguish between 25(OH)D2 and 25(OH)D3. 
Strong binding between the lipophilic 25(OH)D 
and VDBP creates competition with the capturing 
antibody in the assays where 25(OH)D and VDBP 
are not completely separated. Furthermore, the 
discordance between 25(OH)D values from differ-
ent assays is magnified by differences in standardi-
zation of each assay. As the number of 25(OH)D 
methods increases, it will be essential to carefully 
standardize and harmonize all available methods 
to enable the development and use of evidence-
based guidelines. Fortunately, the Vitamin D 
Standardization Program (VDSP) is making sub-
stantial progress towards both goals.
Corresponding author: tomislavpavicic1985@gmail.com 
Vitamin D in extravascular body fluids
Jelena Culej
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
Vitamin D is included in many biological process-
es, especially calcium and phosphate homeostasis, 
but also in modulation of immune system. Diag-
nostic potential of serum vitamin D has become 
subject of many researches, and measurement of 
its serum concentrations has been included in clin-
ical practice. However, due to its role in physiologi-
cal processes, significance of vitamin D in some 
extravascular fluids has been investigated. To ap-
ply appropriate method in extravascular fluid of 
interest, it is important to understand metabolism 
of vitamin D. Inactive form undergoes first hydrox-
ylation process in the liver and it is converted to 
25(OH)D - major circulating form after which is 
converted into active 1,25(OH)2D in kidneys. Most 
of 25(OH)D form is bound to vitamin D binding 
protein (VDBP) which is reabsorbed by tubular 
reuptake mediated by receptors. Excess of vitamin 
D undergoes conjugation processes and its conju-
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gates are excreted by urine. Any tubular damage 
will decrease plasma vitamin D due to impaired tu-
bular reabsorption. Measuring of VDBP in urine 
could give insight into vitamin D loss by kidneys 
and determination of vitamin D glucuronides 
might improve understanding of vitamin D me-
tabolism. Vitamin D expresses its function through 
vitamin D receptors which are abundantly ex-
pressed on brain tissue. Consequently, presence of 
those receptors and modulator role on immune 
system, raised interest in measuring vitamin D in 
cerebrospinal fluid in patients with Alzheimer dis-
ease, and multiple sclerosis. Modulator effect on 
cells of innate and adaptive immune cells led to 
hypothesis that vitamin D could be increased in 
pleural effusion due to infection. Similar was as-
sessed with peritoneal fluid where serum-ascites 
vitamin D gradient was tested in order to diagnose 
spontaneous bacterial peritonitis. Synovial mac-
rophage and fibroblasts are included in 25(OH)D 
metabolism, which increased interest for vitamin 
D determination in synovial fluid in patients with 
rheumatoid arthritis. Concentrations of vitamin D 
have also been investigated in mother’s milk to ex-
amine nutritional value for new-borns and saliva is 
interesting due to its availability as a sample. Al-
though limited, research of vitamin D concentra-
tions in extravascular fluid have potential as diag-
nostic tool in many conditions. 
Corresponding author: jelena.culej@gmail.com
Vitamin D and infertility 
Iva Pitner, Ivan Bolanča 
Department of human reproduction, Sestre milosrdnice 
University Hospital Center, Zagreb, Croatia
The importance of vitamin D and its isoforms; er-
gocalciferol and cholecalciferol, is well known for 
its role in calcium homeostasis and bone minerali-
zation. Vitamin D receptors (VDR) and enzymes re-
quired for the production of active form are ex-
pressed in numerous human cells and tissues, 
which links vitamin D insufficiency or deficiency to 
many diseases such as cancer, autoimmune, infec-
tious and cardiovascular diseases and diabetes 
mellitus. Among all, VDR is expressed in ovarian 
tissue, uterus and placenta as well. 
New theories of vitamin D effect on reproductive 
health have been proposed, in order to improve 
infertility treatment.   
Although results are still inconclusive, existing data 
suggest the possible beneficial role of vitamin D in 
fertility. Besides that, many studies imply that vita-
min D may as well have important role in pregnan-
cy outcomes. Adverse pregnancy outcomes includ-
ing preterm birth, gestational diabetes and preec-
lampsia have been observed in women with vita-
min D deficiency. Also, vitamin D deficiency is 
thought to have several negative effects on human 
fertility. Evidence suggests a correlation between 
vitamin D and ovarian reserve markers, in particular, 
with anti-Mullerian hormone (AMH), suggesting 
that its deficiency may be associated with lower 
ovarian reserve in late reproductive aged women.
Besides, vitamin D might have beneficial effect on 
metabolic and hormonal parameters of PCOS and 
endometriosis, which are one of the most com-
mon reasons of female infertility. Although the ex-
act mechanism how vitamin D affects PCO and en-
dometriosis is not yet known, several explanations 
have been proposed.
The majority of studies demonstrated a positive 
relationship between higher vitamin D status and 
IVF outcome. Recent data imply that vitamin D de-
ficiency has impact on pregnancy success in wom-
en undergoing day 5 single embryo transfer (SET). 
The lower clinical pregnancy rates were attributed 
to a negative effect of vitamin D deficiency on en-
dometrial receptivity. 
Interestingly, epidemiological studies have shown 
seasonal variations in human reproductive capaci-
ty, which could be partially explained by variation 
of vitamin D concentrations throughout year. 
In male infertility both low and high concentra-
tions of vitamin D in serum negatively affect sper-
matozoa number, their progressive movement 
and morphology.  
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Although it is not yet established weather vitamin 
D truly has a role in human fertility, it is the theme 
worth of exploring. 
Corresponding author: ivan.bolanca@gmail.com
Diabetes mellitus and vitamin D
Davorka Herman Mahečić
Department for endocrinology, diabetes and metabolism, 
Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Renewed interest in vitamin D, the so-called “sun-
shine vitamin,” has occurred recently because it 
has been linked to everything from cancer and 
heart disease to diabetes. However, most of the re-
search is based on observational, epidemiological 
studies, which are important for generating hy-
potheses but do not prove causality.
Because destruction of β-cells usually begins in in-
fancy or early childhood and continues until type 
1 diabetes is diagnosed, it is intriguing in terms of 
the utility of vitamin D in people with type 1 dia-
betes. Currently, evidence supports that maintain-
ing adequate vitamin D status during pregnancy, 
nursing, infancy, and childhood may help prevent 
type 1 diabetes. However, it is still unknown 
whether the genetics of type 1 diabetes place in-
dividuals at risk for vitamin D deficiency or wheth-
er vitamin D deficiency places individuals at risk 
for type 1 diabetes.
Some studies have suggested that low vitamin D 
concentrations might increase the odds of devel-
oping type 2 diabetes and that boosting concen-
trations could prevent. Newly published studies 
showed no likely connection between diabetes 
and vitamin D concentrations. Other studies find-
ings suggest that high-dose supplementation of 
vitamin D can improve glucose metabolism to 
help prevent the development and progression of 
diabetes.
Adequate vitamin D supplementation may de-
crease the incidence of type 1 and possibly also of 
type 2 diabetes mellitus and may improve the 
metabolic control in the diabetes state. However, 
the exact mechanisms and the level of protection 
are not clear and need further investigation.
Corresponding author: dherman_cro@yahoo.com 
Vitamin D receptor polymorphisms in 
rheumatic diseases
Alen Vrtaric
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
Vitamin D receptor (VDR) is responsible for biolog-
ical actions of 1,25(OH)2D. VDR is steroid, intracel-
lular receptor, which consists of 427 amino acids 
located on chromosome 12. Dimerization of VDR 
with retinoic X receptor is responsible for activa-
tion of vitamin D target genes and their expres-
sion acting as transcription factor. Immunoregula-
tory properties of vitamin D in the cells of the im-
mune system are mediated by VDR. Main effect of 
vitamin D in the immune system is downregula-
tion of the Th1-driven autoimmunity. Low vitamin 
D concentrations in blood, may, among other fac-
tors, be associated with VDR polymorphisms by 
considering the potential immunosuppressive role 
of vitamin D in rheumatic diseases. Over 63 poly-
morphisms on VDR gene have been examined in 
rheumatic diseases for their association with dis-
ease development. Out of them, rs2228570, 
rs1544410, rs7975232, and rs731236 were the most 
common. Changes can be shown in non-coding 
parts of the gene (introns), and they then would 
not be seen in the protein product. These changes 
would then affect gene expression, and thus pro-
tein concentrations. Changes in the 5′-promoter of 
the VDR gene can affect mRNA expression pat-
terns and concentrations, while 3′ untranslated re-
gion (UTR) sequence variations can affect the 
mRNA stability and protein translation efficiency. 
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Furthermore, changes can take place in exonic 
parts of the DNA leading to changes in the protein 
sequence. However, various authors found hetero-
geneity in results. VDR polymorphisms may be the 
key to understand this heterogeneity. In under-
standing VDR gene polymorphism as a significant 
risk factor for rheumatic diseases, several facts 
need to be considered. Source of heterogeneity 
among studies might have been due to other fac-
tors, such as diversity in the population (age, eth-
nicity, sun exposure and dietary vitamin D intake, 
etc.), study design and genotyping methods. Some 
studies have shown that the ethnic (genetic) back-
ground, gene-gene or gene-environment interac-
tions and lifestyle (sun exposure, dietary vitamin D 
intake, and obesity) might have a significant im-
pact on increased risk of rheumatic diseases in as-
sociation with polymorphisms.
Corresponding author: alenvrtaric@gmail.com 
Vitamin D in lung diseases
Lara Milevoj Kopcinovic
Department of Clinical Chemistry, Sestre milosrdnice University 
Hospital Center, Zagreb, Croatia
The role of vitamin D in regulating calcium home-
ostasis and bone metabolism is well known. How-
ever, vitamin D exerts pleiotropic protective func-
tions including modulation of the adaptive and in-
nate immune response. Its immunomodulatory 
function arises from: a) high affinity binding to the 
ubiquitously distributed vitamin D receptor (VDR) 
(including immune and pulmonary structural 
cells); b) the capacity of many cells and tissues to 
synthesize the active 1,25(OH)2D locally; and c) the 
ability of 1,25(OH)2D to control the transcription of 
various genes associated with multiple biological 
processes through nuclear VDR binding. Altera-
tions in these metabolic pathways together with 
high prevalence of vitamin D insufficiency have 
been linked to chronic lung diseases (e.g. chronic 
obstructive pulmonary disease (COPD), asthma, 
respiratory infections etc.).
The prevalence of vitamin D deficiency is high in 
COPD patients, positively correlates with disease 
severity and is strongly associated with pulmonary 
function and underlying osteoporosis in COPD pa-
tients. Reduced vitamin D concentrations are 
thought to enhance pro-inflammatory pathways 
and reduce immunity in these patients, contribut-
ing to disease deterioration. Vitamin D supple-
mentation in COPD patients reduces morbidity by 
reducing the risk of hip fractures, and might pre-
vent deterioration of pulmonary function.
It was proposed that vitamin D deficiency found in 
asthma patients impairs lung function, promotes 
airway hyperresponsiveness and inflammation, 
and decreases response to glucocorticoids. Animal 
and in vitro studies support these hypotheses. Epi-
demiologic and in vivo studies found an associa-
tion between low serum vitamin D and decline in 
lung function in patients with asthma. However, 
results from clinical trials are conflicting - it is still 
unclear whether vitamin D supplementation of-
fers a valid treatment option in asthma patients. 
Decreased serum vitamin D is associated with in-
creased susceptibility to respiratory tract infec-
tions (i.e. tuberculosis and influenza). However, in-
sufficient evidence is available to define its role in 
prevention and/or treatment of tuberculosis and 
viral upper respiratory tract infections. 
Larger trials with longer follow-up are needed to 
elucidate the molecular mechanisms linking vita-
min D to chronic lung diseases, as well as the ther-
apeutic effects of vitamin D supplementation. 
Corresponding author: laramilevoj@gmail.com 
